Skip to main content
Clinical Trials/NL-OMON39336
NL-OMON39336CompletedPhase 2

MRI-guided High-Intensity Focused Ultrasound Ablation of Breast Cancer - MR-HIFU of breast cancer

niversitair Medisch Centrum Utrecht0 sites10 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
10

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • Female aged 18 years and over
  • Able to give informed consent herself
  • World Health Organization performance score <= 2
  • Weight < 80 kg
  • The target breast fits into the cup of the dedicated MR-HIFU breast system
  • Patients with cT1-2(>= 1.0 cm) invasive breast cancer, confirmed by histopathology. Size of the tumor is determined on mammography or ultrasound

Exclusion Criteria

  • Patients treated with neo-adjuvant systemic therapy
  • Contra-indications for MRI scanning according to the hospital guidelines
  • Contra-indications to injection of gadolinium-based contrast agent, including known prior allergic reaction to any contrast-agent, and renal failure, defined by GFR < 30mL/min/1.73m2
  • Macro calcifications around the targeted tumor
  • Scar tissue or surgical clips in the direct path of the HIFU beam
  • Pregnant or lactating women
  • Patients who don*t want to be informed about unexpected findings on MRI

Investigators

Sponsor
niversitair Medisch Centrum Utrecht

Similar Trials